OHSU Innovation Awards and Celebration, Feb 7
Join the annual celebration of OHSU's innovations and innovators, industry partnerships, entrepreneurship and technology commercialization. At the 2019 OHSU Innovation Awards and...
Tag: TTBD
Travel funds: Talk with potential partners about your innovation
Are you developing an innovation at OHSU that you’d like to talk about with potential partners? Technology Transfer and Business Development is starting a new program to provide innovative teams...
New award to support early-stage technologies
Technology Transfer and Business Development is now offering a technology development award to support promising early-stage technologies. All new inventions and technologies disclosed to TTBD are...
Bringing your inventions to market: How your tech transfer office can help
Technology transfer offices across the nation are celebrating the anniversary of the Bayh-Dole Act and how it has transformed the way universities, non-profit organizations and small businesses...
President Jacobs to open Innovation Awards and Celebration Feb 7: Registration now open
On Feb. 7, the 2019 OHSU Innovation Awards and Celebration will recognize and honor those who have contributed to OHSU’s efforts in innovation, entrepreneurship, industry partnership and...
Tech Transfer and Ximbio create a new life science collaborative research program
OHSU Technology Transfer and Business Development has created an internship with Ximbio, one of the world’s largest non-profit tech transfer services dedicated to life science research. Marie...
2019 OHSU Commercialization Conference: Hold the date and early register by Jan. 31
Hold the date for the annual OHSU Commercialization Conference, hosted by Technology Transfer and Business Development. This year's theme of Fueling Health Care Innovation offers a platform for...
OHSU startup receives FDA Fast Track designation for new blood clot treatment
Blood clots contribute to dangerous, potentially deadly conditions, including venous thromboembolism and stroke. They are also a leading cause of death and long-term disability in the U.S. and...
2018 MedTech Alliance Showcase, Nov. 1
The 2018 MedTech Alliance Showcase, hosted by Technology Transfer and Business Development, highlights the most promising early-stage breakthroughs at OHSU. This year, four inventors will have 10...
Xiangshu Xiao receives $120K to develop new therapy for drug-resistant ovarian cancer
Xiangshu Xiao, Ph.D., and his team were recently awarded $120,000 to develop a new therapy for drug-resistant ovarian cancer. Ovarian cancer is the deadliest gynecological cancer in the U.S., and...